Court to decide whether Illinois nonprofit hospitals have to pay property tax

The Illinois Supreme Court will hear a case challenging the property tax exemption for nonprofit hospitals in the state.

The Chicago Tribune reports hundreds of millions of dollars for hospitals are at stake in the case. The plaintiffs, however, argue nonprofits make more than enough to pay property taxes like other businesses.

“If the law is struck down, then it's going to be a big issue for not-for-profit hospitals across the state," said John Colombo, a tax law professor at the University of Illinois. "I bet a lot of municipalities and taxing jurisdictions would look at this and say, 'Ah-ha, here's an extra $1 million to $2 million or extra $200,000 or $300,000 that will go toward the school, toward fixing the roads,' and they're going to be aggressive about (getting) that."

Illinois has about 156 nonprofit hospitals. Many of the largest did report sizable net income in 2015, like $198 million for Northwestern Memorial Hospital and its 14.8 percent profit margin. A few were in the red, such as Rush University Medical Center in Chicago, which lost $22.7 million in 2015.

Hospitals contend the money saved from not paying property taxes goes to charity care and benefits for the community. Read the full article below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.